We are live on ! Find out more
EIM

Essex Investment Management Portfolio holdings

AUM $632M
1-Year Est. Return 95.36%
This Fund
S&P 500
This Quarter Est. Return
+16.88%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$820M
AUM Growth
+$14.5M
Cap. Flow
-$58.3M
Cap. Flow %
-7.11%
Top 10 Hldgs %
15.04%
Holding
537
New
56
Increased
73
Reduced
203
Closed
92

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$6.12M
2
CRSP icon
CRISPR Therapeutics
CRSP
+$5.37M
3
ST icon
Sensata Technologies
ST
+$5.01M
4
DRIO icon
DarioHealth
DRIO
+$3.05M
5
TWTR
Twitter, Inc.
TWTR
+$3.05M

Sector Composition

Rank Sector Weight
1 Technology 24.55%
2 Healthcare 17.09%
3 Industrials 12.67%
4 Materials 10.49%
5 Consumer Discretionary 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VCEL icon
51
Vericel Corp
VCEL
$2.29B
$4.09M 0.5%
73,699
-27,139
-27% -$1.23M
MP icon
52
MP Materials
MP
$9.64B
$4.08M 0.5%
113,513
+27,355
+32% +$1.01M
NTRA icon
53
Natera
NTRA
$45.5B
$4.03M 0.49%
39,721
-8,129
-17% -$891K
AMN icon
54
AMN Healthcare
AMN
$1.26B
$3.98M 0.49%
54,057
-3,731
-6% -$277K
TER icon
55
Teradyne
TER
$63B
$3.9M 0.48%
32,023
-1,510
-5% -$190K
GDXJ icon
56
VanEck Junior Gold Miners ETF
GDXJ
$8.59B
$3.89M 0.47%
86,516
-17,194
-17% -$846K
B
57
Barrick Mining
B
$67.9B
$3.89M 0.47%
196,626
-25,891
-12% -$558K
RVNC
58
DELISTED
Revance Therapeutics, Inc.
RVNC
$3.88M 0.47%
138,989
+62,318
+81% +$1.72M
EVBG
59
DELISTED
Everbridge, Inc. Common Stock
EVBG
$3.88M 0.47%
31,977
-1,020
-3% -$143K
RAVN
60
DELISTED
Raven Industries Inc
RAVN
$3.86M 0.47%
100,742
+5,673
+6% +$212K
ATEC icon
61
Alphatec Holdings
ATEC
$1.49B
$3.84M 0.47%
243,106
-26,044
-10% -$410K
STZ icon
62
Constellation Brands
STZ
$22.9B
$3.71M 0.45%
16,278
-1,026
-6% -$231K
SIVB
63
DELISTED
SVB Financial Group
SIVB
$3.65M 0.45%
7,400
-4,100
-36% -$2.02M
ITRI icon
64
Itron
ITRI
$4.49B
$3.63M 0.44%
40,939
+10,015
+32% +$990K
BIIB icon
65
Biogen
BIIB
$30.9B
$3.59M 0.44%
12,840
-514
-4% -$139K
APTV icon
66
Aptiv
APTV
$10.1B
$3.57M 0.44%
25,875
+5,873
+29% +$854K
MODN
67
DELISTED
MODEL N, INC.
MODN
$3.45M 0.42%
97,926
-6,297
-6% -$242K
TMDX icon
68
Transmedics
TMDX
$3.02B
$3.45M 0.42%
+83,063
New +$2.56M
WOLF icon
69
Wolfspeed
WOLF
$1.65B
$3.34M 0.41%
30,929
+1,738
+6% +$195K
AXP icon
70
American Express
AXP
$232B
$3.31M 0.4%
23,417
-17
-0.1% -$2.25K
TWTR
71
DELISTED
Twitter, Inc.
TWTR
$3.3M 0.4%
51,913
+49,856
+2,424% +$3.05M
MS icon
72
Morgan Stanley
MS
$342B
$3.3M 0.4%
42,523
BEEM icon
73
Beam Global
BEEM
$25.8M
$3.28M 0.4%
75,680
-6,726
-8% -$354K
GMED icon
74
Globus Medical
GMED
$11.5B
$3.27M 0.4%
53,061
-1,898
-3% -$120K
CSTL icon
75
Castle Biosciences
CSTL
$960M
$3.26M 0.4%
47,618
+12,576
+36% +$945K

Similar funds

Essex Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, Essex Investment Management held 537 positions worth $820M, up 1.8% from $806M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Essex Investment Management withdrew a net $58.3M in Q1 2021, closing 92 positions and reducing 203 holdings. Its most notable exit was VeriSign, an estimated $5.32M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Essex Investment Management opened a new position in CRISPR Therapeutics worth $4.33M.

  • Essex Investment Management's largest Q1 2021 buy was CRISPR Therapeutics: 35,540 shares worth $4.33M.
  • Essex Investment Management added most to AT&T in Q1 2021, an estimated $6.12M increase.
  • Essex Investment Management's biggest Q1 2021 reduction was Teladoc Health, cutting an estimated $8.61M.
  • Essex Investment Management fully exited VeriSign in Q1 2021, selling an estimated $5.32M.
  • Essex Investment Management's ten largest holdings make up 15% of its $820M portfolio in Q1 2021.
  • Essex Investment Management opened 56 new positions and closed 92 in Q1 2021.
  • Essex Investment Management's portfolio value rose 1.8% quarter-over-quarter to $820M.

Based on Essex Investment Management's 13F filing for Q1 2021, filed 12 May 2021.